ObjectiveThe SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and endometrial cancer risk reported conflicting results. We…
Source:MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Sunday, November 3, 2013
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment